Many Medicare Patients Non-Adherent to Antihypertensives
Antihypertensive medication regimens should be made as easy-to-follow as possible
New Anticancer Drugs Up Costs and Life Expectancy Considerably
Lifetime costs up $72,000, life expectancy up 13 months with new drug use in breast cancer
Advanced Glycation End Products Tied to Renal Function Loss
AGEs improve RFL prediction in American-Indians with type 2 diabetes
Liraglutide, Sitagliptin Have No Effect on Renal Hemodynamics
No change in effective renal plasma flow, other intrarenal hemodynamic measures
Limited Dialyzability for Oxycodone, Noroxycodone
Significant mean reduction in oxycodone, noroxycodone arterial concentrations
Obesity May Up Survival in Metastatic Renal Cell Carcinoma
Obese/overweight patients survived 25.6 months, compared to 17.1 months for normal-weight patients
August 2016 Briefing – Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for August 2016. This roundup includes the latest...
Donor, Recipient Characteristics Impact Transplant Costs
Living kidney donor costs up with higher degree of allosensitization; also linked to obesity
ACA Is Helping More Americans Afford Prescriptions
Improvement seen in all age levels, but millions still struggle with the cost of prescription drugs
Higher Incidence of Edema With Bacteriuria in C1-INH-HAE
Findings in those with versus without bacteriuria in hereditary angioedema with C1-inhibitor deficiency
